Metagenomi Therapeutics Inc (MGX) Price Prediction & ForecastMGXMetagenomi Therapeutics Inc

Alphio's MGX stock price prediction model matches the current Metagenomi Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.69 (-1.27%). The 1-week path is $0.69 (-1.49%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Metagenomi Inc (MGX) is not a good buy right now due to its significant financial struggles and negative market sentiment. The current price is $0.70, which is near its 52-week low of $0.60, reflecting a staggering year-to-date change of -57.99%. Additionally, the RSI is at 26.455, indicating that the stock is oversold, but this does not guarantee a rebound. The company reported a Q1 EPS of -0.61, missing expectations, and has a forward P/E ratio of 0, suggesting no earnings growth is anticipated. The main risk is the ongoing losses, with net income for Q2 2026 reported at -27.48 million USD, which raises concerns about financial stability and future viability.

Metagenomi Therapeutics Inc (MGX) last closed at $0.7015, losing -4.01%. These facts feed the 1-day and 1-week MGX price prediction above.